Synexus Polska Sp. z o.o.

At Synexus Polska Sp. z o.o. in Lodz, clinical research in cardiovascular diseases focuses on conditions such as hypertension, atherosclerotic cardiovascular disease, high cardiovascular risk, and established heart and vascular disease. These studies are designed to evaluate new ways to lower major cardiovascular events, improve risk control, and better manage long-term outcomes.

• Testing treatments aimed at reducing heart attack, stroke, and other serious vascular events
• Studying therapies for hypertension and high-risk cardiovascular profiles
• Evaluating approaches to improve prevention in people with established disease

Overall, the site contributes to research that seeks safer and more effective options for people living with cardiovascular risk factors and chronic heart disease.

Research in digestive system diseases centers on chronic liver conditions, especially non-alcoholic steatohepatitis and metabolic dysfunction-associated steatohepatitis, including advanced forms with fibrosis or cirrhosis. The trials aim to assess whether new therapies can improve liver health, slow disease progression, and support better long-term clinical outcomes.

• Studying treatments for NASH and MASH
• Evaluating strategies to improve liver fibrosis and disease resolution
• Assessing therapies intended to reduce liver-related complications

This area represents a major part of the site’s clinical portfolio and reflects a strong focus on chronic liver disease management.

The site is active in immune system diseases, with studies mainly in atopic dermatitis and related inflammatory skin conditions. These trials are aimed at understanding how new treatments can reduce symptoms, improve skin control, and support longer-term safety in people with persistent immune-mediated disease.

• Testing new therapies for moderate-to-severe atopic dermatitis
• Evaluating symptom relief and overall skin improvement
• Observing long-term safety in chronic inflammatory disease

Research in this field also includes allergic conditions, highlighting the site’s broader interest in immune-driven disorders.

Clinical trials in nervous system diseases at this site include work on cognitive impairment associated with post-COVID-19 syndrome. The main purpose is to evaluate whether investigational treatments can improve cognitive function and help address lingering neurological symptoms after infection.

• Studying interventions for post-COVID cognitive impairment
• Assessing changes in objective cognitive outcomes
• Exploring options to support recovery after viral illness

This research reflects growing attention to the long-term neurological effects of COVID-19.

In nutritional and metabolic diseases, the trials focus on obesity, type 2 diabetes mellitus, and liver-related metabolic disorders such as NASH. The research is intended to test new therapies that may help with weight management, blood sugar control, and reduction of metabolic complications.

• Evaluating treatments for obesity and excess body weight
• Studying therapies for type 2 diabetes mellitus
• Assessing metabolic disease treatments that may also benefit liver health

These studies support a broad effort to improve care for people with interconnected metabolic conditions.

Research in respiratory tract diseases includes asthma, chronic obstructive pulmonary disease, and seasonal allergic rhinitis. The trials are designed to evaluate therapies that may improve breathing symptoms, reduce flare-ups, and support better control of chronic airway inflammation.

• Testing new options for moderate-to-severe asthma
• Studying treatments for COPD and exacerbation prevention
• Evaluating allergy-related respiratory symptom relief

At this site, respiratory research spans both chronic lung disease and pollen-related allergic conditions.

Clinical trials in skin and connective tissue diseases mainly address atopic dermatitis and recurrent herpes labialis. The purpose of this research is to examine whether new or existing treatments can improve visible symptoms, reduce discomfort, and offer better tolerability for patients with recurring skin problems.

• Studying therapies for atopic dermatitis
• Evaluating treatments for recurrent herpes labialis
• Assessing long-term safety and symptom control in chronic skin disease

This area shows a strong emphasis on inflammatory and infectious skin conditions.

The site also conducts research in virus diseases, including studies on respiratory syncytial virus infections and recurrent herpes labialis. These trials aim to better understand immune response, evaluate preventive approaches, and test treatments that may reduce the impact of viral illness.

• Assessing immune response in RSV-related studies
• Testing therapies for recurrent herpes labialis
• Exploring ways to improve prevention and symptom control in viral conditions

This infectious disease research adds an important preventive and treatment-focused dimension to the site’s portfolio.